Your browser doesn't support javascript.
loading
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.
Scott, Robert A; Scott, Laura J; Mägi, Reedik; Marullo, Letizia; Gaulton, Kyle J; Kaakinen, Marika; Pervjakova, Natalia; Pers, Tune H; Johnson, Andrew D; Eicher, John D; Jackson, Anne U; Ferreira, Teresa; Lee, Yeji; Ma, Clement; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Qi, Lu; Van Zuydam, Natalie R; Mahajan, Anubha; Chen, Han; Almgren, Peter; Voight, Ben F; Grallert, Harald; Müller-Nurasyid, Martina; Ried, Janina S; Rayner, Nigel W; Robertson, Neil; Karssen, Lennart C; van Leeuwen, Elisabeth M; Willems, Sara M; Fuchsberger, Christian; Kwan, Phoenix; Teslovich, Tanya M; Chanda, Pritam; Li, Man; Lu, Yingchang; Dina, Christian; Thuillier, Dorothee; Yengo, Loic; Jiang, Longda; Sparso, Thomas; Kestler, Hans A; Chheda, Himanshu; Eisele, Lewin; Gustafsson, Stefan; Frånberg, Mattias; Strawbridge, Rona J; Benediktsson, Rafn; Hreidarsson, Astradur B; Kong, Augustine.
Afiliación
  • Scott RA; MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Scott LJ; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI.
  • Mägi R; Estonian Genome Center, University of Tartu, Tartu, Estonia.
  • Marullo L; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
  • Gaulton KJ; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Kaakinen M; Department of Genetics, Stanford University, Stanford, CA.
  • Pervjakova N; Department of Genomics of Common Disease, Imperial College London, London, U.K.
  • Pers TH; Estonian Genome Center, University of Tartu, Tartu, Estonia.
  • Johnson AD; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Eicher JD; Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA.
  • Jackson AU; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ferreira T; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Lee Y; Framingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Framingham, MA.
  • Ma C; Framingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Framingham, MA.
  • Steinthorsdottir V; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI.
  • Thorleifsson G; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Qi L; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI.
  • Van Zuydam NR; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI.
  • Mahajan A; deCODE genetics, Amgen, Inc., Reykjavik, Iceland.
  • Chen H; deCODE genetics, Amgen, Inc., Reykjavik, Iceland.
  • Almgren P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Voight BF; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Grallert H; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Müller-Nurasyid M; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Ried JS; Pat Macpherson Centre for Pharmacogenetics and Pharmacogenomics and Biomedical Research Institute, Ninewells Hospital, University of Dundee, Dundee, U.K.
  • Rayner NW; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Robertson N; Human Genetics Center and Department of Epidemiology, Human Genetics & Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
  • Karssen LC; Center for Precision Health, School Biomedical Informatics, and School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
  • van Leeuwen EM; Lund University Diabetes Centre and Department of Clinical Sciences Malmö, University Hospital Scania, Lund University, Malmö, Sweden.
  • Willems SM; Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Fuchsberger C; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kwan P; Institute of Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Teslovich TM; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Chanda P; Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Li M; German Center for Diabetes Research, Neuherberg, Germany.
  • Lu Y; Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Dina C; Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.
  • Thuillier D; Genetic Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Yengo L; Munich Heart Alliance, German Centre for Cardiovascular Disease, Munich, Germany.
  • Jiang L; Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Sparso T; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Kestler HA; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
  • Chheda H; Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Eisele L; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Gustafsson S; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
  • Frånberg M; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Strawbridge RJ; PolyOmica, 's-Hertogenbosch, the Netherlands.
  • Benediktsson R; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Hreidarsson AB; MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Kong A; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Diabetes ; 66(11): 2888-2902, 2017 11.
Article en En | MEDLINE | ID: mdl-28566273
To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci (P < 5 × 10-8), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants. Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes. Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action-associated loci. These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Población Blanca / Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Población Blanca / Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Año: 2017 Tipo del documento: Article
...